Clinical Trials in Massachusetts

Showing 17381-17400 of 17,868 trials

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00085891

The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine compared to placebo in patients with schizophrenia after receiving treatment for up to 6 weeks.

Schizophrenia

AstraZeneca535 participantsStarted Jun 2004

Birmingham, Alabama, United States • Cerritos, California, United States • Los Angeles, California, United States +26 more locations

COMPLETEDPhase 322 miles

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

NCT00326105

The purpose of this study is to evaluate the efficacy of quetiapine SR in combination with an antidepressant versus an antidepressant alone in patients with MDD with inadequate response to an antidepressant treatment. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Major Depressive Disorder

AstraZeneca450 participantsStarted Apr 2006

Phoenix, Arizona, United States • El Centro, California, United States • Irvine, California, United States +53 more locations

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Find Trials by Condition in Massachusetts

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

Photochemical Tissue Bonding

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Prospective Evaluation of the Fluid Rapid Influenza Test

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus

Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Study of Picoplatin Efficacy After Relapse